Nanoparticle dsDNA Delivery for Innate Immunity and Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating infectious diseases, such as those caused by pathogens like bacteria, viruses, fungi, or parasites, are inadequate in effectively boosting the immune response and providing comprehensive treatment options.
Innovation Solution
The use of nanoparticles to deliver double-stranded DNA (dsDNA) intracellularly, which stimulates the innate immune response and can be combined with therapeutic agents or vaccines to enhance immune response and treat infectious diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapeutic agents or vaccines are used alone, then treatment is provided, but immune response boosting is insufficient
Solution Approach 1:
The patent combines dsDNA adjuvant with conventional vaccines or therapeutic agents into a single nanoparticle formulation. This merging allows the immune-boosting dsDNA to work synergistically with the therapeutic agent, simultaneously achieving both immune response enhancement and pathogen targeting in one administration.
Solution Approach 2:
The dsDNA acts as an intermediary substance that bridges the gap between conventional therapeutic agents and the host immune system. It mediates the interaction by stimulating innate immune pathways (cGAS/STING and inflammasome) to create a more robust immune environment that enhances the effectiveness of the co-administered vaccine or therapeutic agent.
2Reliability
If immune response is boosted through multiple separate treatments, then immune enhancement may be achieved, but treatment complexity increases
Solution Approach 1:
Multiple functional components (dsDNA adjuvant and therapeutic agent/vaccine) are merged into a single nanoparticle formulation, eliminating the need for separate administrations. This single combined treatment achieves both immune enhancement and therapeutic effects, simplifying the treatment regimen while maintaining efficacy.
Solution Approach 2:
The nanoparticle formulation serves multiple functions simultaneously: it delivers the therapeutic agent, provides adjuvant activity through dsDNA stimulation of innate immunity, and enables intracellular delivery. This multi-functionality in a single platform reduces treatment complexity compared to using multiple separate treatments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enhances the immune response and provides effective treatment for infectious diseases by stimulating the innate immune system through dsDNA delivery, offering adjuvant activity and targeted immune boosting.
Implementation Method 1
The nanoparticles are able to deliver the dsDNA intracellularly where the dsDNA can stimulate the innate immune response
Data Source
AI summary
The present invention features methods utilizing nanoparticles for double-stranded DNA (dsDNA). The nanoparticles are able to deliver the dsDNA intracellularly where the dsDNA can stimulate the innate immune response. Uses of the described methods include enhancing an immune response to a vaccine and infectious disease treatment.